BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$0.30
+0.00 (+0.41%)
Open$0.30
Previous Close$0.30
Day High$0.31
Day Low$0.28
52W High$2.05
52W Low$0.19
Volume—
Avg Volume2.67M
Market Cap6.40M
P/E Ratio—
EPS$-1.48
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+8,705.5% upside
Current
$0.30
$0.30
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 1.95M | 1.76M |
| Net Income | -25,837,300 | 368.5K | 288.6K |
| Profit Margin | -2,239.3% | 18.9% | 16.4% |
| EBITDA | -27,065,946 | 506.9K | 503.0K |
| Free Cash Flow | — | 427.1K | 335.8K |
| Rev Growth | +100.2% | +23.8% | +14.5% |
| Debt/Equity | — | 0.56 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |